Boeing (NYSE: BA) Stock Gains 8.24% in 30 Days After 737-7 Approval, but Valuation Signals 44.8% Overvaluation

Boeing (NYSE: BA) stock has gained 8.24% over the past 30 days as investors respond to improving conditions in the company’s commercial aircraft business. A major catalyst came on August 3, 2026, when the U.S. Federal Aviation Administration certified Boeing’s long-delayed 737-7 for commercial service. The approval supports Boeing’s recovery story, but a reported 44.8% overvaluation signal raises a concern for investors: has BA stock already priced in too much optimism?

Boeing 737-7 Approval Gives BA Stock a Fresh Catalyst

Why the August 3 FAA Certification Matters?

The FAA certified Boeing’s 737-7 on August 3, 2026, clearing a major hurdle for the long-delayed aircraft. The certification followed years of testing and additional safety requirements introduced after the 737 MAX crashes and the 2024 Alaska Airlines incident. The aircraft can carry 135 to 160 passengers and offers about 10% more range than other MAX variants. Southwest Airlines will be the launch customer, although deliveries are not expected to enter its operations until after March 2027.

Approval is only the first test.

Boeing's 737-7 approval matters more than the market reaction. The verified milestone moves the aircraft forward; I think the harder question is whether Boeing can turn regulatory progress into consistent execution.#Boeing #AviationTech pic.twitter.com/wu37B7FLkH

— It’s me, Joe (@AllAboutJoeX) August 17, 2026

737 MAX 7 Backlog and Delivery Opportunity

The approval gives Boeing a route to deliver aircraft that have already been built. About 30 MAX 7 jets were awaiting certification when the FAA approved the aircraft. Boeing also has 282 unfilled MAX 7 orders, giving the company a sizeable delivery pipeline. The next step is to turn that backlog into revenue while keeping production on track.

BA Stock Performance: Why Shares Have Gained 8.24% in 30 Days

FAA Approval and Improving Investor Sentiment

Boeing shares jumped 6.7% after the August 3 certification, according to Reuters. Barron’s reported a stronger move, with BA closing at $233.49 after an 8% gain. The reaction shows how quickly investor sentiment changed after the regulatory approval. The market now has a clearer path to Boeing’s commercial aircraft recovery.

Q2 2026 Results Strengthen the Recovery Case

Boeing’s July 28 results also added support to the recovery story. Second-quarter revenue reached $24.56 billion, up 8% from a year earlier. The company delivered 171 commercial aircraft, while operating cash flow reached $1.36 billion. Free cash flow also turned positive at $631 million, compared with negative $200 million a year earlier.

Boeing Valuation Raises a Key Warning for Investors

Why BA Stock May Look Expensive?

The recent rally has also raised valuation concerns. Meyka’s latest fundamental data shows BA trading at 79.43 times earnings and 30.09 times book value. Its debt-to-equity ratio is 7.89, while its operating margin remains negative at -5.89%. Those numbers suggest investors are already paying a high price for a turnaround that Boeing still needs to deliver.

The reported 44.8% overvaluation signal is best viewed as a valuation warning rather than a prediction that the stock must fall.

Meyka AI Outlook for Boeing Stock

Meyka’s current forecast remains cautious. Its model projects BA at $209.40 over one month, $261.46 over one quarter, and $201.71 over one year. Its five-year projection is $189.62. Meyka labels both its short-term and long-term outlook bearish, even with the improvement seen in recent quarterly results.

Investors can use an AI stock analysis tool to compare technical signals, valuation figures, and price forecasts before making investment decisions.

Boeing Delivery Growth Is the Next Test for BA Stock

Production Rates and July Delivery Data

Boeing still needs to show that the 737-7 approval can translate into consistent deliveries. The company delivered 53 aircraft in July, down 17% from 64 in June. Airbus delivered 67 during the same month. Boeing has also started moving its 737 programme towards a production rate of 47 aircraft per month, with further increases planned.

Wall Street just turned the most bullish on Boeing since 2022. The company is still losing money.

Not one of 32 analysts rates $BA a sell. Yet Boeing is set to lose 83 cents a share this year and throw off $2.44 billion in free cash, a fifth of the $13.6 billion it generated in… pic.twitter.com/7zubevtj3g

— Kurt S. Altrichter, CRPS® (@kurtsaltrichter) August 16, 2026

What Investors Should Watch Next?

Investors should keep an eye on 737 production, 737-10 certification, 787 output, and free cash flow. Boeing expects the 737-10 to gain certification in 2026, with its first delivery planned for 2027. The company also ended June with a record $715 billion backlog, including more than 6,200 commercial aircraft.

Boeing Stock Outlook: Recovery Story or Overvalued Rally?

The bullish case for BA stock rests on higher production, 737-7 certification, improving cash flow, and Boeing’s record backlog. Valuation remains the main concern. Meyka’s technical analysis shows neutral sentiment, an RSI of 44.86, and resistance near $241.53. Major analysts are more positive. JPMorgan has a $290 target, while Baird has set its target at $300.

Conclusion

Boeing has made progress, but BA stock still faces a demanding test. The 737-7 approval removes one major hurdle, while higher deliveries and positive free cash flow support the recovery. Still, high valuation metrics and mixed technical signals add risk after the recent rally. Investors should watch production, cash generation, and certification progress before deciding whether Boeing stock can continue moving higher.

Disclaimer:

The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.